| Literature DB >> 31907196 |
Na Jia1, Hong-Bo Liu2, Yuan-Chun Zheng3, Wen-Qiang Shi1, Ran Wei1, Yan-Li Chu3, Nian-Zhi Ning1, Bao-Gui Jiang1, Rui-Ruo Jiang1, Tao Li1, Qiu-Bo Huo3, Cai Bian3, Xiong Liu1,2, Yi Sun1, Lian-Feng Li1, Qian Wang1, Wei Wei1, Ya-Wei Wang1, Frans Jongejan4,5, Jia-Fu Jiang1, Ju-Liang Song3, Hui Wang6, Wu-Chun Cao6.
Abstract
Spotted fever group rickettsia (SFGR) can cause mild to fatal illness. The early interaction between the host and rickettsia in skin is largely unknown, and the pathogenesis of severe rickettsiosis remains an important topic. A surveillance of SFGR infection by PCR of blood and skin biopsy specimens followed by sequencing and immunohistochemical (IHC) detection was performed on patients with a recent tick bite between 2013 and 2016. Humoral and cutaneous immunoprofiles were evaluated in different SFGR cases by serum cytokine and chemokine detection, skin IHC staining, and transcriptome sequencing (RNA-seq). A total of 111 SFGR cases were identified, including 79 "Candidatus Rickettsia tarasevichiae," 22 Rickettsia raoultii, 8 Rickettsia sibirica, and 2 Rickettsia heilongjiangensis cases. The sensitivity to detect SFGR in skin biopsy specimens (9/24, 37.5%) was significantly higher than that in blood samples (105/2,671, 3.9%) (P < 0.05). As early as 1 day after the tick bite, rickettsiae could be detected in the skin. R. sibirica infection was more severe than "Ca Rickettsia" and R. raoultii infections. Increased levels of serum interleukin-18 (IL-18), IP10, and monokine induced by gamma interferon (MIG) and decreased levels of IL-2 were observed in febrile patients infected with R. sibirica compared to those infected with "Ca Rickettsia." RNA-seq and IHC staining could not discriminate between SFGR-infected and uninfected tick bite skin lesions. However, the type I interferon (IFN) response was differently expressed between R. sibirica and R. raoultii infections at the cutaneous interface. It is concluded that skin biopsy specimens were more reliable for the detection of SFGR infection in human patients although the immunoprofile may be complicated by immunomodulators induced by the tick bite.Entities:
Keywords: Rickettsia; pathogenesis; rickettsiosis; skin biopsy specimens; transcriptome
Mesh:
Substances:
Year: 2020 PMID: 31907196 PMCID: PMC7093127 DOI: 10.1128/IAI.00686-19
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441
FIG 1Significantly different levels of expression of serum cytokine or chemokine in “Ca. Rickettsia” patients with and without fever (A) and in febrile patients with “Ca. Rickettsia” or R. sibirica infection (B). *, P < 0.05; **, P < 0.01. CRT, “Candidatus Rickettsia tarasevichiae.”
FIG 2Immunohistochemical detection (hematoxylin counterstain) of Rickettsia raoultii in the skin biopsy specimen of a patient with R. raoultii infection. Original magnification, ×1,000.
FIG 3Hierarchical clustering analysis of overall gene expression by transcriptome evaluation on tick-fed skin biopsy specimens from SFGR-infected or uninfected patients. Fed-tick information, the interval between tick bite and skin sample collection, and the skin biopsy specimen type were included in the clustering analysis. NA, not available. D. silvarum, Dermacentor silvarum; I. persulcatus, Ixodes persulcatus.
FIG 4Hematoxylin and eosin (HE) staining, and immunophenotyping by lymphocyte (CD3), neutrophils (CD15), and macrophages (CD68) on serial sections of samples from patients 2, 5, and 11 (see Table S3 in the supplemental material). Magnification, ×200; inset magnification, ×400. Peroxidase (brown) was used for immunostaining.
Transcripts of the type I pathway induced in skin biopsy specimens of R. sibirica infection relative to levels with R. raoultii infection
| Gene name | Description | Relative expression in: | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| s1 vs r1 | s1 vs r2 | s1 vs r3 | s2 vs r1 | s2 vs r2 | s2 vs r3 | ||||||||
| Log2 FC | Log2 FC | Log2 FC | Log2 FC | Log2 FC | Log2 FC | ||||||||
|
IFIT2 | IFN-induced protein with tetratricopeptide repeats 2 | 2.40E−09 | 8.78787 | 1.41E−08 | 3.36166 | 9.67E−07 | 2.25908 | 2.20E−64 | 16.87193 | 1.84E−70 | 12.28032 | 5.72E−37 | 6.703528 |
| RSAD2 | Radical | 4.78E−07 | 8.204539 | 9.92E−11 | 5.268731 | 1.38E−08 | 2.71806 | 5.45E−62 | 16.55291 | 1.42E−71 | 14.43458 | 1.57E−35 | 6.509623 |
| ISG15 | ISG15 ubiquitin-like modifier | 0.002435 | 6.457162 | 0.000194 | 4.411335 | 2.68E−07 | 2.88902 | 5.20E−45 | 14.27856 | 1.71E−54 | 13.03666 | 6.48E−30 | 5.816973 |
| IFIT3 | IFN-induced protein with tetratricopeptide repeats 3 | 9.35E−18 | 10.37792 | 1.07E−13 | 3.903858 | 0.032548 | 0.92007 | 6.54E−59 | 16.14215 | 3.11E−60 | 10.50377 | 7.95E−30 | 5.721682 |
| MX2 | MX dynamin-like GTPase 2 | 3.76E−05 | 2.118935 | 2.57E−12 | 3.735954 | 0.000906 | 1.44553 | 6.00E−42 | 7.883568 | 10.18116 | 1.47E−57 | 5.49E−25 | 5.041784 |
| IFIT1 | IFN-induced protein with tetratricopeptide repeats 1 | 8.49E−10 | 8.872573 | 2.89E−14 | 5.937531 | 1.40E−07 | 2.42459 | 5.47E−51 | 15.0825 | 1.59E−60 | 12.96415 | 2.66E−22 | 4.663792 |
| OASL | 2'-5'-Oligoadenylate synthetase like | 7.40E−07 | 7.875647 | 2.01E−07 | 3.994897 | 0.018371 | 1.16953 | 3.06E−33 | 12.66724 | 1.82E−42 | 9.614755 | 1.90E−20 | 4.501635 |
| GBP2 | Guanylate binding protein 2 IFN inducible | 4.09E−21 | 4.897447 | 0.000739 | 1.427524 | 0.004756 | 1.185573 | 2.81E−34 | 6.762797 | 1.19E−17 | 3.97486 | 2.32E−16 | 3.772888 |
| HLA-C | Major histocompatibility complex class I, C | 6.79E−22 | 6.31561 | 0.01114 | 1.08249 | 0.010307 | 1.07963 | 6.00E−44 | 9.434273 | 1.10E−23 | 4.886665 | 3.00E−10 | 2.764606 |
| OAS3 | 2'-5'-Oligoadenylate synthetase 3 | 2.67E−21 | 6.227064 | 0.003659 | 1.246947 | 0.001064 | 1.38771 | 3.63E−42 | 9.193872 | 1.02E−23 | 4.899251 | 9.12E−08 | 2.304688 |
| IFITM1 | IFN-induced transmembrane protein 1 | 1.08E−12 | 9.483692 | 0.010353 | 1.200392 | 0.025493 | 0.9894 | 2.44E−24 | 11.39066 | 6.93E−16 | 3.944462 | 3.68E−05 | 1.795146 |
| OAS2 | 2'-5'-Oligoadenylate synthetase 2 | 4.41E−18 | 6.482564 | 2.33E−14 | 3.91359 | 0.000492 | 1.49385 | 1.22E−33 | 8.769977 | 1.48E−34 | 6.889158 | 0.000318 | 1.523028 |
| PTPN1 | Protein tyrosine phosphatase nonreceptor type 1 | 0.000784 | 1.659851 | 0.013215 | 1.118948 | 0.039233 | 0.89303 | 2.67E−09 | 2.941685 | 3.16E−11 | 3.08255 | 0.009438 | 1.110821 |
The comparisons are indicated as follows: s1 and s2 represent R. sibirica-infected cases 1 and 2, respectively; r1, r2, and r3 represent R. raoultii-infected cases 1, 2, and 3, respectively. FC, fold change in expression level.